Bachem Holding AG Logo

Bachem Holding AG

A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.

BANB | SW

Overview

Corporate Details

ISIN(s):
CH1176493729
LEI:
506700S81111XI7TG884
Country:
Switzerland
Address:
Hauptstrasse 144, 4416 Bubendorf
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bachem Holding AG is a leading, technology-driven biochemical company specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience, the company operates as a Contract Development and Manufacturing Organization (CDMO), providing a comprehensive portfolio of products and services to the global pharmaceutical and biotechnology industries. Bachem supports its clients throughout the entire lifecycle of their products, from research and clinical development to the large-scale commercial production of complex organic molecules and Active Pharmaceutical Ingredients (APIs).

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-20 02:00
Board/Management Information
Bachem expands Corporate Executive Committee to include Chief Operations Office…
English 5.3 KB
2025-08-20 02:00
Board/Management Information
Bachem erweitert Konzernleitung um die Rolle des Chief Operations Officer
German 5.8 KB
2025-07-24 02:00
Earnings Release
Bachem shows strong growth in the first half of 2025
English 10.8 KB
2025-07-24 02:00
Earnings Release
Bachem mit starkem Wachstum im ersten Halbjahr 2025
German 12.1 KB
2025-06-03 02:00
Regulatory News Service
Bachem mourns the loss of company founder Dr. h.c. Peter Grogg
English 4.7 KB
2025-06-03 02:00
Board/Management Information
Bachem trauert um Firmengründer Dr. h.c. Peter Grogg
German 7.7 KB
2025-02-27 01:00
Earnings Release
Bachem increases sales and profitability
English 9.7 KB
2025-02-27 01:00
Earnings Release
Bachem erhöht Umsatz und Profitabilität
German 11.3 KB
2024-07-25 02:00
Report Publication Announcement
Bachem with slight sales growth in the first half of 2024. Outlook confirmed fo…
English 7.9 KB
2024-07-25 02:00
Report Publication Announcement
Bachem mit leichtem Umsatzplus im ersten Halbjahr 2024. Ausblick für das Gesam…
German 8.5 KB
2024-05-28 02:00
Legal Proceedings Report
Incident on construction site of Bachem in Bubendorf
English 2.9 KB
2024-05-28 02:00
Legal Proceedings Report
Vorfall auf Baustelle der Bachem in Bubendorf
German 3.1 KB
2024-04-24 02:00
Post-Annual General Meeting Information
Bachem Annual General Meeting 2024
English 3.8 KB
2024-04-24 02:00
Post-Annual General Meeting Information
Bachem - Ordentliche Generalversammlung 2024
German 4.1 KB
2024-03-07 01:00
Earnings Release
Bachem continues to grow and increases dividend
English 9.7 KB

Automate Your Workflow. Get a real-time feed of all Bachem Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Bachem Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-06 N/A Non-Executive member Buy None 30,315.25 CHF

Peer Companies

Company Country Ticker View
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea 291650
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden AROC
Ascelia Pharma Logo
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden ACE
Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.
Japan 4886
Astellas Pharma Inc. Logo
A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.
Japan 4503

Talk to a Data Expert

Have a question? We'll get back to you promptly.